Invention Grant
- Patent Title: C
-
Application No.: US18203823Application Date: 2023-05-31
-
Publication No.: US11945778B2Publication Date: 2024-04-02
- Inventor: Jillian M. Hagel , Kaveh Matinkhoo , Peter J. Facchini
- Applicant: Enveric Biosciences Canada Inc.
- Applicant Address: CA Calgary
- Assignee: Enveric Biosciences Canada Inc.
- Current Assignee: Enveric Biosciences Canada Inc.
- Current Assignee Address: CA Calgary
- Agency: BERESKIN & PARR LLP/ S.E.N.C.R.L., s.r.l.
- Agent Michael Fenwick
- Main IPC: A61K31/4045
- IPC: A61K31/4045 ; A61P25/00 ; C07D209/16 ; C07D209/20 ; C07D401/12 ; C07D403/12 ; C07D405/12
Abstract:
Disclosed are novel C4-carbonothioate-substituted tryptamine derivative compounds and pharmaceutical and recreational drug formulations containing the same. The pharmaceutical formulations may be used to treat brain neurological disorders.
Public/Granted literature
- US20230321040A1 C4-CARBONOTHIOATE-SUBSTITUTED TRYPTAMINE DERIVATIVES AND METHODS OF USING Public/Granted day:2023-10-12
Information query
IPC分类:
